IDEAYA Biosciences, Inc., a precision medicine oncology company, has announced the issuance of non-qualified stock options to nine newly hired employees, under its 2023 Employment Inducement Incentive Award Plan. The stock options, totaling 664,600 shares, are granted as an inducement for employment under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $20.05 per share, matching the closing price of IDEAYA's common stock on the grant date, and come with a 10-year term. Vesting occurs over four years, with 25% vesting on the first anniversary and the remainder vesting monthly over the next three years, contingent upon continued employment.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。